Capital Market
-
ข่าว
Foreigner and Prop Trade Buoy SET Index by 4.5pts with THB697 Million of Net Buy
The total value of buying and selling on December 22, 2021, categorized by the investor's type.
-
ข่าว
Thai Stock Market Roundup on 22 December 2021
A brief summary of major changes and significant developments in the Thai stock market on December 22, 2021.
-
Breaking News
Global Equity Markets are Muted as Traders Awaits Key Economic Numbers
Traders on cautious mode as they assess upcoming key economic data and impact from suring omicron cases globally
-
Breaking News
Treasuries Dipped Slightly as Investors Awaits Key Economic Data and Omicron
Key economic data to be released on Wednesday to shape the direction of the global markets
-
Kaohoon International
RBF’s Share Gains 11% ahead of the Hemp Harvest in Early 2022
RBF rose THB2.20/share or 10.58% to THB23.00/share, with a trading value of THB823 million
-
Kaohoon International
XO Climbs 5% as Sauce Sales Still Strong, Analyst Recomm. “BUY”
Analyst anticipates a 38% increase in XO's profit in 4Q21, as global supply-chain problems have begun to ease since November, and there is still a plenty of demand for sauces
-
ข่าว
CNS Is Positive on JMART from JMT-KBANK Partnership, Seeing Outperforming Results in 4Q
Capital Nomura Securities has positive view on the partnership between JMT and KBANK, seeing outperforming results in 4Q21.
-
Kaohoon International
Kaohoon’s Top News on December 22, 2021
Top news from “Kaohoon Turakij Newspaper” to start the trading day on December 22, 2021
-
ข่าว
Stocks in Focus on December 22, 2021: IVL and JMART
Stocks in Focus on December 22, 2021: IVL (Krungsri Securities TP at ฿60.00/share) and JMART (Maybank Securities TP at ฿60.00/share).
-
Breaking News
Singapore Freezes Quarantine Free Travel amid Rising Cases of Omicron Globally
Singaporean Health Ministry in a statement announced to freeze quarrantine free travel into the country
-
ข่าว
MINT Improves Liquidity by Divesting Ownership in 2 Subsidiaries for THB3,500 Million
MINT divested 40% ownership in two subsidiaries to improve liquidity and reduce debts.
-
Breaking News
AstraZeneca with Oxford to Produce Omicron Targetted Vaccine
According to Financial Times, researchers at Oxford are working with AstraZeneca to produce omicron targeted vaccine